Skip to main content
SpringerLink
Log in

Immunologisch bedingte Krankheiten

  • Chapter
Medizinische Therapie in Klinik und Praxis

  • 92 Accesses

Zusammenfassung

Bei den primären Immundefekten handelt es sich vorwiegend um sehr seltene Erkrankungen, deren Inzidenz vielfach in der Größenordnung von 1:1.000.000 oder darunter liegt. Das Management dieser Patienten erfordert daher die enge Zusammenarbeit zwischen dem betreuenden Haus- oder Kinderarzt, Ärzten aus immunologischen Schwerpunktzentren sowie weiteren Fachärzten wie z. B. Dermatologen, Pulmonologen und Gastroenterologen. Die Therapieeinleitung wird in immunologischen Schwerpunktzentren begonnen, in denen die Patienten auch in regelmäßigen Abständen vorstellig werden sollten.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 54.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

Literatur

  • Bordignon C, Notarangelo L D, Nobili N et al. (1995) Gene therapy in peripheral blood lymphocytes and bone marrow for ADA-immunodeficient patients. Science 270: 470–475

    Article  PubMed  CAS  Google Scholar 

  • Buckley RH, Fischer A (1999) Bone marrow transplantation for primary immunodeficiency diseases. In: Ochs HD, Smith CIE, Puck JM (eds) Primary immunodeficiency diseases: A molecular and genetic approach, 1st edn. Oxford University Press, Oxford, pp 459–475

    Google Scholar 

  • Candotti F, Blaese RM (1999) Gene therapy. In: Ochs HD, Smith CIE, Puck JM (eds) Primary immunodeficiency diseases: A molecular and genetic approach, 1st edn. Oxford University Press, Oxford, pp 476–489

    Google Scholar 

  • Conley ME, Stiehm ER (1996) Immunodeficiency disorders: general considerations. In: Stiehm ER (ed) Immunologic disorders in infants and children, 4th edn. WB Saunders, Philadelphia, pp 201–252

    Google Scholar 

  • Cunningham-Rundles C, Siegal FP, Smithwick EM, Lion-Boulé A, Cunningham-Rundles S, O’Malley J, Barandun S, Good RA (1984) Efficacy of intravenous immunoglobulin in primary humoral immunodeficiency disease. Ann Intern Med 101: 435–439

    Article  PubMed  CAS  Google Scholar 

  • Fischer A, Landais P, Friedrich W et al. (1994) Bone marrow transplantation (BMT) in Europe for primary immunodeficiencies other than severe combined immunodeficiency: a report from the European Group for BMT and the European Group for Immunodeficiency. Blood 83: 1149–1154

    PubMed  CAS  Google Scholar 

  • Fischer A, Landais P, Friedrich W et al. (1990) European experience of bone-marrow transplantation for severe combined immunodeficiency. Lancet 336: 850–854

    Article  PubMed  CAS  Google Scholar 

  • Friedrich W, Goldmann SF, Ebell W, Blutters-Sawatzki R, Gaedicke G, Raghavachar A, Peter HH, Belohradsky B, Kreth W, Kubanek B, et al. (1985) Severe combined immunodeficiency: treatment by bone marrow transplantation in 15 infants using HLA-haploidentical donors. Eur J Pediatr. 144: 125–30

    Article  PubMed  CAS  Google Scholar 

  • Garbett ND, Currie DC, Cole PI (1989) Comparison of the clinical efficacy and safety of an intramuscular and an intravenous immunoglobulin preparation for replacement therapy in idiopathic adult onset panhypogammablobulinaemia. J Clin Exp Immunol 76: 1–7

    CAS  Google Scholar 

  • Gardulf A, Anderson V, Bjorkander J et al. (1995) Subcutaneous immunoglobulin replacement in patients with primary antibody deficiencies: safety and costs. Lancet 345: 365–369

    Article  PubMed  CAS  Google Scholar 

  • Liese JG, Jendrossek V, Jansson A, Petropoulou T, Kloos S, Gahr M, Belohradsky BH (1996) Chronic granulomatous disease in adults. Lancet 347: 220–3

    Article  PubMed  CAS  Google Scholar 

  • Stiehm ER (1999) Conventional therapy of primary immunodeficiency diseases. In: Ochs HD, Smith CIE, Puck JM (eds) Primary immunodeficiency diseases: A molecular and genetic approach, 1st edn. Oxford University Press, Oxford, pp 448–458

    Google Scholar 

Literatur

  • Bousquet J, Lockey R, Mailing HJ (1998) Allergen immunotherapy: therapeutic vaccines for allergic diseases. A WHO position paper. J Allergy Clin Immunol 102: 558–562

    Google Scholar 

  • Cauwenberge P van, Bachert C, Passalacqua G et al. (2000) Consensus statement on the treatment of allergic rhinitis. Eur Acad Allergol Clin Immunol Allergy 5: 116–134

    Article  Google Scholar 

  • Grattan C, Powell S, Humphreys F (2001) Management and diagnostic guidelines for urticaria and angio-oedema. Br J Dermatol 144: 708–714

    Article  PubMed  CAS  Google Scholar 

  • Greaves MW (2001) Antihistamines. Dermatol Clin 19: 53–62 Henz BM, Zuberbier T, Grabbe J (Hrsg) ( 2000 ) Urtikaria - Klinik, Diagnostik, Therapie. Springer, Berlin Heidelberg New York Tokyo

    Google Scholar 

  • Holgate ST, Church MK, Kapp A (Hrsg) (1996) Allergologie. Ullstein, Berl in Wiesbaden

    Google Scholar 

  • Klimek L, Reske-Kunz AB, Saloga J (Hrsg) (1999) Spezifische Immuntherapie - Hyposensibilisierung. Thieme, Stuttgart New York

    Google Scholar 

  • Ring J (Hrsg) (1995) Angewandte Allergologie. MMW-Verlag, München

    Google Scholar 

  • Roitt IM, Brostoff DK, Male DK (Hrsg) (1987) Kurzes Lehrbuch der Immunologie. Thieme, Stuttgart New York

    Google Scholar 

  • Vignola AM, Bousquet J (2001) Rhinitis and asthma: a continuum of disease? Clin Exp Allergy 31: 674–677

    Article  PubMed  CAS  Google Scholar 

Literatur

  • ACR clinical guidelines committee (1996) Arthritis Rheum 39: 723–731

    Article  Google Scholar 

  • Branch DW, Silver RM, Blackwell JL, Reading JC, Scott JR (1992) Outcome of treated pregnancies in women with anti-phospholipid syndrome: an update of the Utah experience. Obstet Gynecol 80: 614–620

    PubMed  CAS  Google Scholar 

  • Burt RK, Marmont A, Schroeder J, Rosa R, Traynor AE (2000) Intense immune suppression for systemic lupus–the role of hematopoietic stem cells. J Clin Immunol 20: 31–37

    Article  PubMed  CAS  Google Scholar 

  • Chan TM, Li FK, Tang CS et al. (Hong Kong-Guangzhou Nephrology Study Group) (2000) Efficacy of mycophenolate mofetil in patients with diffuse proliferative lupus nephritis. N Engl J Med 343: 1156–1162

    Google Scholar 

  • Diehm C, Heidrich H, Sprengel F, Schulte KL, Theis W (2000) Die medikamentöse Therapie der arteriellen Verschlusskrankheit. Internist 41: 1416–1422

    Article  CAS  Google Scholar 

  • Dooley MA, Falk RJ (1998) Immunosuppressive therapy of lupus nephritis. Lupus 7: 630–634

    Article  PubMed  CAS  Google Scholar 

  • Hallegua D, Wallace DJ, Metzger AL, Rinaldi RZ, Klinenberg JR (2000) Cyclosporine for lupus membranous nephritis: experience with ten patients and review of the literature. Lupus 9: 241–251

    Article  CAS  Google Scholar 

  • Klippel JH, Weyand CM, Wortmann RL (eds) (1997) Primer of the rheumatic diseases, 11th edn. Arthritis Foundation, Georgia

    Google Scholar 

  • Lorenz HM, Herrmann M, Winkler T, Gaipl U, Geiler T, Kalden Jr., (2000) A role for apoptosis in autoimmunity. Apoptosis 5: 441–447

    Article  Google Scholar 

  • Mojcik CF, Klippel JH (1996) End stage renal disease and systemic lupus erythematosus. Am J Med 101: 100–107

    Article  PubMed  CAS  Google Scholar 

  • Ostensen M, Ramsey-Goldman R (1998) Treatment of inflammatory rheumatic disorders in pregnancy: what are the safest treatment options? Drug Saf 19: 389–410

    Article  CAS  Google Scholar 

  • Reinhold-Keller E, Beuge N, Latza U et al. (2000) An interdisciplinary approach to the care of patients with Wegener’s granulomatosis: long-term outcome in 155 patients. Arthritis Rheum 43: 1021–1032

    Article  PubMed  CAS  Google Scholar 

  • Spinatto JA, Clark AL, Pierangeli SS, Harris EN (1995) Intravenous immunoglobulin therapy for the antiphospholipid syndrome in pregnancy. Am J Obstet Gynecol 172: 690–694

    Article  Google Scholar 

  • Wilder RL (1997) Corticosteroids. In: Klippel JH, Weyand CM, Wortmann RL (eds) Primer of the rheumatic diseases. Arthritis Foundation, Atlanta

    Google Scholar 

Literatur

  • Avisar R, Savir H, Machtey I, Ovaknin L, Shaked P, Menache R, Allalouf D (1981) Clinical trial of bromhexine in Sjögren’s syndrome. Ann Ophtalmol 13: 971–973

    CAS  Google Scholar 

  • El-Mallakh RS, Bryan RK, Masi AT, Kelly CE, Akowski KJ (1985) Long term low dose glucocorticoid therapy associated with remission of overt tubular acidosis in Sjögren’s sydrome. Am J Med 79: 509–514

    Article  PubMed  CAS  Google Scholar 

  • Gunduz K, Ozdemir 0 (1994) Topical cyclosporin treatment of keratoconjunctivitis sicca in secondary Sjögren’s syndrome. Acta Ophtalmol 72: 438–442

    CAS  Google Scholar 

  • Kruize AA, Hene RJ, Kallenberg CG, van Bijsterveld OP, van der Heide A, Kater L, Bijlsma JW (1993) Hydroxychloroquine treatment for primary Sjögren’s syndrome: a two year double blind crossover trial. Ann Rheum Dis 52: 360–364

    Article  PubMed  CAS  Google Scholar 

  • Marsh P, Pflugfelder SC (1999) Topical nonpreserved methylprednisolone therapy for keratoconjunctivitis sicca in Sjögren’s syndrome. Ophtalmology 106: 811–816

    Article  CAS  Google Scholar 

  • Oxholm P, Asmussen K, Axell T et al. (1995) Sjögren’s syndrome: terminology. Clin Exp Rheumatol 13: 693–696

    PubMed  CAS  Google Scholar 

  • Oxholm P, Prause JU, Schiodt M (1998) Rational drug therapy recommendations for the treatment of patients with Sjögren’s syndrome (Review). Drugs 56 (3): 345–353

    Article  PubMed  CAS  Google Scholar 

  • Reveille JD (1992) The molecular genetics of systemic lupus erythematosus and Sjögren’s syndrome (Review). Curr Opin Rheumatol 4 (5): 644–656

    PubMed  CAS  Google Scholar 

  • Vitali C, Bombardieri S, Moutsopoulos HM et al (The European study group on diagnostic criteria for Sjögren’s syndrome) (1996) Assessment of the European classification criteria for Sjögrens’s syndrom in a series of clinically defined cases: results of a prospective multicentre study. Ann Rheum Dis 55: 116–121

    Google Scholar 

  • Vivino FB, Al-Hashimi I, Khan Z et al. (P92–01 Study Group) (1999) Pilocarpine tablets for the treatment of dry mouth and dry eye symptoms in patients with Sjögren syndrome: a randomized, placebo-controlled, fixed-dose, multicenter trial. Arch Intern Med 159: 74–81

    Google Scholar 

Literatur

  • Bohan A, Peter JB, Bowman RL, Pearson CM (1977) A computer-assisted analysis of 153 patients with polymyositis and dermatomyositis. Medicine (Baltimore) 56: 255–286

    CAS  Google Scholar 

  • Buchbinder R, Forbes A, Hall S, Dennett X, Giles G (2001) Incidence of malignant disease in biopsy-proven inflammatory myopathy. Ann Intern Med 134: 1087–1095

    Article  PubMed  CAS  Google Scholar 

  • Dalakas MC (1991) Polymyositis, dermatomyositis and inclusion-body myositis. N Engl J Med 325: 1487–1498

    Article  PubMed  CAS  Google Scholar 

Weiterführende Literatur

  • Clements PJ, Lachenbruch PA, Ng SC et al. (1990) Skin score. A semiquantitative measure of cutaneous involvement that improves prediction of prognosis in systemic sclerosis. Arthritis Rheum 33: 1256–1263

    Article  PubMed  CAS  Google Scholar 

  • Clements PJ, Furst DE, Wong WK et al. (1999) High dose versus low dose D-penicillamine in early diffuse systemic sclerosis: analysis of a two year, double blind, randomized, controlled clinical trial. Arthritis Rheum 42: 1194–1203

    Article  CAS  Google Scholar 

  • Hoeper MM, Schwarze M, Ehlerding S et al. (2000) Long term treatment of primary pulmonary hypertension with aerolized iloprost, a prostacyclin analogue. N Engl J Med 342: 1866–1870

    Article  PubMed  CAS  Google Scholar 

  • Kuwana M, Kaburaki J, Okano Y, Tojo T, Homma M (1994) Clinical and prognostic associations based on serum antinuclear antibodies in japanese patients with systemic sclerosis. Arthritis Rheum 37: 75–83

    Article  PubMed  CAS  Google Scholar 

  • LeRoy EC, Krieg T, Black C et al. (1988) Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 15: 202–205

    PubMed  CAS  Google Scholar 

  • Lock G, Holstege A, Lang B, Schölmerich J (1997) Gastrointestinal manifestations of progressive systemic sclerosis. Am J Gastroenterol 92: 763–771

    PubMed  CAS  Google Scholar 

  • Steen VD, Constantino JP, Shapiro AP, Medsger TA (1990) Outcome of renal crisis in systemic sclerosis: relation to availability of angiotensin converting enzyme ( ACE) inhibitors. Ann Int Med 113: 352–357

    Google Scholar 

  • Steen VD, Medsger TA (1998) Case-control study of corticosteroids and other drugs that either precipitate or protect from the development of scleroderma renal crisis. Arthritis Rheum 41: 1613–1619

    Article  PubMed  CAS  Google Scholar 

  • Tyndall A, Black C, Finke J, Peter H, Gratwohl A (1997) Treatment of systemic sclerosis with autologous hemopoetic stem cell transplantation. Lancet 349: 254–356

    Article  PubMed  CAS  Google Scholar 

  • White B, Moore WC, Wigley FM et al. (2000) Cyclophosphamide is associated with pulmonary function and survival benefit in patients with scleroderma and alveolitis. Ann Int Med 132: 947–954

    PubMed  CAS  Google Scholar 

Literatur

  • De Groot K, Gross WL, Herlyn K et al. (2001) Development and validation of a disease extent index in Wegener’s granulomatosis. Clin Nephrol 55: 31–38

    PubMed  Google Scholar 

  • Gross WL (1999) Primär systemische Vaskulitiden, Teil III: Pathogenese und Therapie. Internist 40: 1194–1215

    Article  PubMed  CAS  Google Scholar 

  • Gross WL (Hrsg) (2000) Therapie der Immunvaskulitiden. UniMed-Verlag, Bremen

    Google Scholar 

  • Jayne DR, Chapel H, Adu D et al. (2000) Intravenous immunoglobulin for ANCA-associated systemic vasculitis with persistent disease activity. Quart J Med 93: 433–439

    Article  CAS  Google Scholar 

  • Jayne D (2000) Evidence-based treatment of systemic vasculitis. Rheumatol 39: 585–595

    Article  CAS  Google Scholar 

  • Reinhold-Keller E, Beuge N, Latza U et al. (2000) An interdisciplinary approach to the care of patients with Wegener’s granulomatosis: long-term outcome in 155 patients. Arthritis Rheum 43: 1021–1032

    Article  PubMed  CAS  Google Scholar 

  • Zeuzem S, Feinman SV, Rasenack J et al. (2000) Peginterferon alfa-2a in patients with chronic hepatitis C. N Engl J Med 343: 1723–1724

    Article  Google Scholar 

Literatur

  • Aktulga E, Altac M, Özyazgan Yet al. (1980) A double blind study of colchicine in Behçet’s disease. Haematologica 65: 339–402

    Google Scholar 

  • Barnes CG, Yasici H (1999) Behçet’s syndrome (editorial). Rheu-matology 38: 1171–1176

    Article  CAS  Google Scholar 

  • Hamuryadan V, Özyazgan Y, Hizli N et al. (1997) Azathioprine in Behçet’s syndrome. Effects on long-term prognosis. Arthritis Rheum 40: 769–774

    Article  Google Scholar 

  • International Study Group for Behçet’s disease (1990) Criteria for diagnosis of Behçet’s disease. Lancet 335: 1078–1080

    Google Scholar 

  • Kaldamani VG, Kaldamanis PG (2001) Treatment of Behçet’s die- sease–an update. Semin Arthritis Rheum 30: 299–312

    Article  Google Scholar 

  • Whitcup SM, Salvo EC, Nussenblatt RB (1994) Combined cyclosporine and corticosteroid therapy for sight-threatening uveitis in Behçet’s disease. Am J Ophthalmol 118: 39–45

    PubMed  CAS  Google Scholar 

  • Yasici H, Barnes CG. (1991) Practical treatment recommendations for pharmacotherapy of Behçet’s syndrome. Drugs 42: 796–804

    Article  Google Scholar 

Literatur

  • Benning K, Müller-Ladner U, Rau G, Lang B (1993) Die chronisch rezivierende Polychondritis. Z Rheumatol 52: 142–149

    PubMed  CAS  Google Scholar 

  • Damiani JM, Levine HL (1979) Relapsing polychondritis. Laryn-goscope 89: 929–946

    CAS  Google Scholar 

  • McAdam LP, O’Hanlan MA, Bluestone R, Pearson CM (1976) Relapsing polychondritis: prospective study of 23 patients and a review of the literature. Medicine 55: 193–215

    Article  PubMed  CAS  Google Scholar 

  • Molina JF, Espinoza LR (2000) Relapsing polychondritis. Baillieres Clin Rheumatol 14: 97–109

    Article  CAS  Google Scholar 

  • Park JK, Gowin M, Schuhmacher HR Jr (1996) Steroid sparing effect of methotrexate in relapsing polychondritis. J Rheumatol 23: 937–938

    PubMed  CAS  Google Scholar 

  • Sarodia BD, Dasgupta A, Mehta AC (1999) Management of airway manifestations of relapsing polychondritis. Case reports and review of the literature. Chest 116: 1669–1675

    Google Scholar 

  • Trentham DE, Le CH (1998) Relapsing polychondritis. Ann Intern Med 129: 114–122

    Article  PubMed  CAS  Google Scholar 

Literatur

  • Braun N, Bosch T (2000) Immunoadsorption, current status and future developments. Exp Opin Invest Drugs 9: 2017–2038

    Article  CAS  Google Scholar 

  • Felson DT, LaValley MP, Baldassare AR, Block JA, Caldwell JR, Cannon GW et al. (1999) The Prosorba column for treatment of refractory rheumatoid arthritis. Arthritis Rheum 42: 2153–2159

    Article  PubMed  CAS  Google Scholar 

  • Lewis EJ, Hunsicker LG, Lan SP, Rohde RD, Lachin JM (The Lupus Nephritis Collaborative Study Group) (1992) A controlled trial of plasmapheresis therapy in severe lupus nephritis. N Engl J Med 326: 1373–1379

    Google Scholar 

  • Snyder HW Jr., Mittelman A, Oral A, Messerschmidt GL, Henry DH, Korec S et al. (1993) Treatment of cancer chemotherapy-associated thrombotic thrombocytopenic purpura/hemolytic uremic syndrome by protein A immunoadsorption of plasma. Cancer 71: 1882–1892

    Article  PubMed  Google Scholar 

Download references

Authors
  1. Johann O. Schröder
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Bodo Grimbacher
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Michael Sticherling
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Hanns-Martin Lorenz
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Frank Moosig
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Beatrix Volc-Platzer
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. N. Hunzelmann
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Angela Gause
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Andreas Ehlert
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Ulf Müller-Ladner
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Norbert Braun
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Teut Risler
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Klinik und Poliklinik für Innere Medizin I, Klinikum der Universität, D-93042, Regensburg, Deutschland

    Jürgen Schölmerich

  2. Universitätsklinik und Poliklinik für Kinder- und Jugendmedizin, Martin-Luther-Universität Halle-Wittenberg, Ernst-Grube-Straße 40, 06120, Halle, Deutschland

    Stefan Burdach

  3. Abteilung Hämatologie, Onkologie Klinik I für Innere Medizin, Universität zu Köln, Joseph-Stelzmann-Straße 9, 50924, Köln, Deutschland

    Volker Diehl

  4. Abteilung Kardiologie und Angiologie, Medizinische Hochschule Hannover, Carl-Neuberg-Straße 1, 30625, Hannover, Deutschland

    Helmut Drexler

  5. Medizinische Klinik und Poliklinik III, Klinikum Großhadern — Universität München, Marchioninistraße 15, 81377, München, Deutschland

    Wolfgang Hiddemann

  6. Innere Medizin III Klinische Abteilung für Nephrologie und Dialyse, Allgemeines Krankenhaus, Währinger Gürtel 18-20, A-1090, Wien, Österreich

    Walter H. Hörl

  7. Klinik und Poliklinik für Psychiatrie und Psychotherapie, Bezirksklinikum Regensburg, Universitätsstraße 84, 93053, Regensburg, Deutschland

    Helmfried Klein

  8. Klinik und Poliklinik für Dermatologie, Universität Regensburg, Franz-Josef-Strauß-Allee 11, 93053, Regensburg, Deutschland

    Michael Landthaler

  9. Medizinische Abteilung mit Intensivstation, Konventhospital der Barmherzigen Brüder Linz, Seilerstätte 2, A-4021, Linz, Österreich

    Kurt Lenz

  10. Abteilung für Endokrinologie Zentrum für Innere Medizin, Universitätsklinikum Essen, Hufelandstraße 55, 45147, Essen, Deutschland

    Klaus Mann

  11. Abteilung Gastroenterologie 6 Hepatologie Medizinische Klinik und Poliklinik, Universität Leipzig, Philipp-Rosenthal-Straße 27, 04103, Leipzig, Deutschland

    Joachim Mössner

  12. Klinik und Poliklinik für Innere Medizin I, Universität Regensburg, Franz-Joseph-Strauß-Allee 11, 93042, Regensburg, Deutschland

    Ulf Müller-Ladner

  13. Institut für Klinische Pharmakologie, Inselspital — Universität Bern, Murtenstraße 35, CH-3010, Bern, Schweiz

    Jürg Reichen

  14. Medizinische Universitätsklinik Knappschaftskrankenhaus, Ruhr-Universität Bochum, In der Schornau 23-25, 44892, Bochum, Deutschland

    Wolff Schmiegel

  15. Abt. Gastroenterologie, Hepatologie, Universitätsklinikum Bergmannsheil, Bürkle-de-la-Camp-Platz 1, 44789, Bochum, Deutschland

    Wolff Schmiegel

  16. II. Medizinische Klinik und Poliklinik Städtisches Krankenhaus, Christian-Albrechts-Universität Kiel, Chemnitzstraße 33, 24116, Kiel, Deutschland

    Johann Oltmann Schröder

  17. Zentrum für Innere Medizin Medizinische Klinik und Poliklinik II, Justus-Liebig-Universität, Klinikstraße 36, 35385, Gießen, Deutschland

    Werner Seeger

  18. Innere Medizin IV Medizinische Klinik und Poliklinik, Ruprecht-Karls-Universität, Bergheimer Straße 58, 69115, Heidelberg, Deutschland

    Wolfgang Stremmel

  19. Sektion Infektiologie Medizinische Klinik Campus Virchow Klinikum, Humboldt Universität, Augustenburger Platz 1, 13353, Berlin, Deutschland

    Norbert Suttorp

  20. Klinische Toxikologie, Giftinformation II. Medizinische Klinik und Poliklinik, Johann-Gutenberg-Universität Mainz, Langenbeckstraße 1, 55131, Mainz, Deutschland

    L. Sacha Weilemann

Rights and permissions

Reprints and permissions

Copyright information

© 2003 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Schröder, J.O. et al. (2003). Immunologisch bedingte Krankheiten. In: Schölmerich, J., et al. Medizinische Therapie in Klinik und Praxis. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-12451-2_3

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-12451-2_3

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-662-12452-9

  • Online ISBN: 978-3-662-12451-2

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation